Sign In

​​​​​​​​​​​​​​​​​ ​​​​​Home Funds and Performance Reliance ​Pharma Fund.​ ​​​​​​​

Reliance Pharma Fund

An Open Ended Pharma Sector Scheme

Product Label Close

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • Investment in equity and equity related securities of pharma and other associated companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them

investMore investMore
  • Investment Objective:
    The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of pharma and other associated companies.

Fund PerformanceGrowth Plan - Growth Option

  • Latest NAV (21 May 2018)133.4992


NAV as on Apr 28, 2018: ` 143.8297

Performance of Reliance Pharma Fund as on 30/04/2018
Particulars1 Year CAGR %3 Year CAGR %5 Year CAGR %Since Inception
Reliance Pharma Fund 9.713.1315.7421.13
B: S&P BSE Healthcare (TRI)-5.17-3.8410.8714.84
AB: S&P BSE Sensex (TRI)18.8810.7114.1516.52
Value of `10000 Invested
Reliance Pharma Fund 10,97710,96920,776143,829
B: S&P BSE Healthcare (TRI)9,4808,89016,76068,516
AB: S&P BSE Sensex (TRI)11,90013,57219,38783,909
Inception Date: Jun 5, 2004
​​​B - Benchmark    |   AB - Additional Benchmark |   TRI - Total Return Index
​​​Fund Manager: Sailesh Raj Bhan (Since Jun 2004)​
As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE Healthcare PRI values from 04/06/2004 to 31/12/2007 and TRI values since 31/12/2007.
As TRI data is not available since inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE Sensex PRI values from 04/06/2004 to 31/05/2007 and TRI values since 31/05/2007.
​​

​​PERFORMANCE OF OTHER OPEN ENDED SCHEMES MANAGED BY FUND MANAGER: Sailesh Raj Bhan

Scheme Name/sCAGR %
1 Year Return 3 Years Return5 Years Return
Scheme Benchmark Scheme Benchmark Scheme Benchmark
Reliance Consumption Fund-2.6725.2510.7016.9512.5517.61​
Reliance Multi Cap Fund14.4517.229.2613.5117.4516.90​
Reliance Large Cap Fund15.3716.7511.7011.8018.4115.07​
​​​

​​Note​:

a.Mr. Shailesh Raj Bhan manages 4 open-ended schemes of Reliance Mutual Fund.

​b. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein.

c. Period for which scheme’s performance has been provided is computed basis last day of the month-end preceding the date of advertisement.

d. Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).

TRI - Total Returns Index reflects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns.

The performance of the equity scheme is benchmarked to the Total Return variant of the Index.

Mr. Sailesh Raj Bhan has been managing Reliance Pharma Fund since Jun 2004, Reliance Consumption Fund since Sep 2004, Reliance Multi Cap Fund since Mar 2005, Reliance Large Cap Fund since Aug 2007

Past performance may or may not be sustained in future and the same may not necessarily provide the basis for comparison with other Investment. Dividends (if any) are assumed to be reinvested at the prevailing NAV. In case of LIQUIDBEES, returns are based on gross dividend per unit declared by the Fund. Bonus (if any) declared has been adjusted. Performance of dividend option would be Net of Dividend distribution tax, if any. Face value of scheme is `10/- per unit. Face Value of Reliance Money Manager Fund is `1000/- per unit. Face Value of Reliance Liquidity Fund, Reliance Liquid Fund - Treasury Plan & Reliance Liquid Fund - Cash Plan is `1000/- per unit w.e.f 5th Aug 2012. Face value of Reliance ETF Junior BeES is `1.25/- per unit. Face value of Reliance ETF Liquid BeES is `1000/- per unit. Face value of Reliance ETF Gold BeES is `100/- per unit. In case, the start/end date of the concerned period is non-business day (NBD), the NAV of the previous date is considered for computation of returns. Schemes which have not completed one year, performance details for the same are not provided. Performance details of closed ended schemes are not provided since these are not comparable with other schemes.​​​

​​​​​ ​​​ ​​​​​
Read more

Fund Details

  • Inception Date5 Jun 2004
  • Fund ManagerMr. Sailesh Raj Bhan
Current Investment Philosophy
    • The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses.
    • The fund invests across market capitalization within the sector.
    • It may suit investment horizon of around 2-3 years.
Minimum Investment
5000.00

    and in multiples of Re. 1 thereafter

Fund Manager
Load Details

Entry Load*:

Not Applicable

*In terms of SEBI circular no. SEBI/IMD/CIR No.4/ 168230/09 dated June 30, 2009, no entry load will be charged by the Scheme to the investor effective August 1, 2009. Upfront commission shall be paid directly by the investor to the AMFI registered Distributors based on the investors' assessment of various factors including the service rendered by the distributor.

Exit Load**:

1% if redeemed or switched out on or before completion of 1 year from the date of allotment of units.

Nil, thereafter.

**If charged, the same shall be credited to the scheme immediately net of Goods & Service tax, if any.

Product label

This product is suitable for investors who are seeking*:

  • Long term capital growth.
  • Investment in equity and equity related securities of pharma and other associated companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them



Close

Portfolio

Select

Details as on Apr 30 , 2018

​​

​​Related Downloads & Tools

Tools

  • SIP Calculator​​​​​​​​​​​​​​​​​​​​​​​​​​​​

How to Invest?

Contact our advisor to complete the process

Other funds in such category

Reliance Banking Fund An open ended equity scheme investing in Banking sector.-Growth Plan Growth Option

Latest NAV

261.3655 21-May-2018

Reliance Power & Infra Fund (formerly known as Reliance Diversified Power Sector Fund) An Open Ended Equity Scheme investing in power & infrastructure sectors-Growth Plan - Growth Option

Latest NAV

106.8014 21-May-2018

Reliance Consumption Fund (formerly known as Reliance Media & Entertainment Fund) An Open Ended Media & Entertainment Sector Scheme-Growth Plan - Growth Option

Latest NAV

61.8009 21-May-2018

Get access to our latest factsheets

Submit

Get the app